AllianceBernstein
MRVI icon

AllianceBernstein’s Maravai LifeSciences MRVI Stock Holding History

AllianceBernstein’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$517K Sell
159,101
-11,500
-7% -$39K ﹤0.01% 2621
2025
Q4 		$554K Sell
170,601
-17,700
-9% -$59.6K ﹤0.01% 2609
2025
Q3 		$540K Hold
188,301
– – ﹤0.01% 2634
2025
Q2 		$454K Buy
188,301
+45,781
+32% +$96.2K ﹤0.01% 2700
2025
Q1 		$315K Buy
142,520
+7,550
+6% +$29.8K ﹤0.01% 2753
2024
Q4 		$736K Hold
134,970
– – ﹤0.01% 2476
2024
Q3 		$1.12M Hold
134,970
– – ﹤0.01% 2263
2024
Q2 		$966K Sell
134,970
-36,100
-21% -$312K ﹤0.01% 2317
2024
Q1 		$1.48M Sell
171,070
-20,159
-11% -$136K ﹤0.01% 2070
2023
Q4 		$1.25M Buy
191,229
+91,777
+92% +$593K ﹤0.01% 2168
2023
Q3 		$995K Sell
99,452
-12,899
-11% -$142K ﹤0.01% 2253
2023
Q2 		$1.4M Buy
112,351
+75,861
+208% +$1.02M ﹤0.01% 2099
2023
Q1 		$511K Sell
36,490
-17,702
-33% -$254K ﹤0.01% 2559
2022
Q4 		$775K Sell
54,192
-65,688
-55% -$1.03M ﹤0.01% 2405
2022
Q3 		$3.06M Sell
119,880
-129,221
-52% -$3.24M ﹤0.01% 1629
2022
Q2 		$7.08M Sell
249,101
-206,120
-45% -$6.53M ﹤0.01% 1283
2022
Q1 		$16.1M Buy
455,221
+310,858
+215% +$10.4M 0.01% 1017
2021
Q4 		$6.05M Buy
144,363
+90,694
+169% +$3.67M ﹤0.01% 1519
2021
Q3 		$2.63M Buy
53,669
+9,600
+22% +$468K ﹤0.01% 2000
2021
Q2 		$1.84M Buy
44,069
+9,009
+26% +$349K ﹤0.01% 2244
2021
Q1 		$1.25M Buy
+35,060
New +$1.16M ﹤0.01% 2323

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's MRVI Position: Q1 2026 in Review

AllianceBernstein reduced its Maravai LifeSciences (MRVI) stake by 6.7% in Q1 2026, selling an estimated $39K and leaving 159,101 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #2621.

AllianceBernstein first reported a position in MRVI in Q1 2021 and has held it in 21 quarters since. The position peaked at $16.1M in Q1 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • AllianceBernstein held 159,101 shares of Maravai LifeSciences worth $517K as of Q1 2026.
  • AllianceBernstein sold 11,500 Maravai LifeSciences shares in Q1 2026, an estimated $39K.
  • Maravai LifeSciences made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2621 holding.
  • AllianceBernstein first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 21 quarters since.
  • AllianceBernstein's Maravai LifeSciences position peaked at $16.1M in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.